
A new open co-folding model with best-in-class performance! Mol-1 from @MolenceBio is out on Tamarind Bio, try it out today.

Tamarind is a interface to the leading molecular AI models such as AlphaFold, used by tens of thousands of scientists + majority of top 20 biopharma

A new open co-folding model with best-in-class performance! Mol-1 from @MolenceBio is out on Tamarind Bio, try it out today.

New de novo design model from Baker Lab + NVIDIA, available on Tamarind today. We are excited to be working with @NVIDIAHealth to bring access to RFD4-Proteina on day 0.

BioEmu2 already available on @tamarindbio app.tamarind.bio/tools/bioem…
Public preview of BioEmu2! @MSFTResearch AI for Science’s new foundation model for biomolecular structure, dynamics and function. Open weights, MIT license. github.com/microsoft/bioemu2 Movie: BioEmu2-simulated binding of intrinsically disordered peptide PUMA to MCL-1 receptor. 🧵⬇️

RFD4-Proteina is available on @tamarindbio today, alongside hundreds of molecular design models. Tamarind also offers a streamlined workflow for fine-tuning the model on your own data. Try it out: app.tamarind.bio/tools/rfd4-…

BindCraft2 is out, ready to use on Tamarind on day one. The workflow expands on the original BindCraft substantially. Most notably, now supporting VHH, scFv, Fab, and seven other binder modalities, supporting multi-state targets, and multiple targets at once.

Claude speeds up molecular design models: 4x on average @AnthropicAI took open biomolecular modeling tools like ESMFold2, OpenDDE, and RFdiffusion, and let Claude (Science) optimize the model kernels, the part of the software interfacing with underlying hardware, in got a 4x average speed improvement without major accuracy losses.

OpenAI's Rosalind Workbench is now in research preview. We're excited to make the Tamarind Bio catalog of 300+ molecular design models available in Rosalind Workbench, available in ChatGPT from day one.

Introducing the Tamarind Model Router. You want to know which molecular AI model will work best for this specific input, not which model wins on average. Tamarind runs hundreds of scientific AI models, and picks the best tool for the job. buff.ly/lzL1wNY

This week @AnthropicAI showed Claude designing de novo protein binders against 14 of 15 targets. They released the protocol, so we built it into a hosted product you can run today. Introducing the Tamarind Protein Design Agent.

AlphaFold3 is no longer the best model. Over the past year, we've seen many (mostly companies) claim that their newly released models matched or outperformed AlphaFold3 in some important structure prediction task. A substantive amount of these also underperformed their self-professed benchmarks under independent scrutiny. This is why I was initially skeptical on the results from the ESMFold2, Protenix-v2, and OpenDDE teams' respective releases. Within a few weeks of each others, these groups each released benchmarks showing meaningful outperformance over AF3.

Thrilled to partner with @NVIDIAHealth to bring optimized AI tools for molecular design to more scientists We're making NVIDIA NIM microservices and BioNeMo Agent Toolkit available on @TamarindBio. This means NVIDIA's optimized models are available, alongside the rest of your open, proprietary and fine-tuned molecular design tools.

Big news today: New Boltz models! De novo design, protein binding affinity prediction, ADME prediction We've partnered with the @Boltz_Bio team to make their next generation proprietary models available on @TamarindBio on day 0. Here are the highlights:

We’re proud to share that @TamarindBio has been selected to build, host, and operate the inference infrastructure layer for TuneLab2.0, the next evolution of the platform. @EliLillyandCo TuneLab is a first-of-its-kind, collaborative AI/ML drug discovery platform, bringing models trained on over $1B worth of Lilly proprietary data to the biotech ecosystem. Tamarind will power TuneLab’s scalable drug discovery workflows and model inference.

ESMFold2 and the ESM-C family, now available for use! We’ve partnered with @biohub (the ESM team’s new home), to provide day 1 access to their newly open-sourced series of models. The family of models show best-in-class results for structure prediction, de novo design, and protein-language model tasks.

We've launched 300+ molecular AI models on Tamarind. Today, we're giving you the system we use to do it. Introducing Custom Tools 🧵

A new best-in-class structure predictor AND de novo design protocol Protenix-v2 claims to outperform AlphaFold3 in antibody-antigen structure prediction tasks, showing a 13% increase over its previous generation in DockQ scores. Available on @tamarindbio today. Protenix-v2 with only 5 seeds beats Protenix-v1 with 1000 seeds on antibody–antigen prediction. This implies a technical improvement, while not needing to massively scale inference of a given model like other providers previously showed. In addition, the authors use Protenix-v2 as a scoring and ranking mechanism for de novo antibody design. They report a 100% target-level success rate on the current soluble-target panel, meaning at least one confirmed binder for every tested target, with BLI-confirmed VHH-Fc hit rates from 2% to 48%. They also show that epitope choice matters a lot: on AMBP, one epitope gave 4% hit rate and another 48%. The GPCR result is probably the most impressive experimental result in the paper. With only 16–30 tested designs per target, the protocol shows VHH-Fc hit rates of 16%, 62%, 40%, and 88% across four GPCRs, and corresponding mAb hit rates of 0%, 17%, 50%, and 44%. They also report a best GPRC5D VHH-Fc binder of 112 pM under avidity conditions. Congratulations to the @ai4s_protenix team on the release!